Summary
UnitedHealth Group is contesting an IRS proposal to increase its taxable income due to how it priced transactions with a foreign subsidiary between 2017 and 2020. This dispute is part of a broader IRS initiative to scrutinize transfer pricing by multinational corporations, with similar cases involving billions of dollars.